全文获取类型
收费全文 | 1690625篇 |
免费 | 126536篇 |
国内免费 | 9531篇 |
专业分类
耳鼻咽喉 | 23697篇 |
儿科学 | 52876篇 |
妇产科学 | 44550篇 |
基础医学 | 234112篇 |
口腔科学 | 45639篇 |
临床医学 | 149354篇 |
内科学 | 334016篇 |
皮肤病学 | 36316篇 |
神经病学 | 126813篇 |
特种医学 | 65849篇 |
外国民族医学 | 732篇 |
外科学 | 254954篇 |
综合类 | 54912篇 |
现状与发展 | 25篇 |
一般理论 | 425篇 |
预防医学 | 119378篇 |
眼科学 | 38228篇 |
药学 | 132535篇 |
160篇 | |
中国医学 | 11656篇 |
肿瘤学 | 100465篇 |
出版年
2021年 | 14330篇 |
2019年 | 13861篇 |
2018年 | 19379篇 |
2017年 | 15645篇 |
2016年 | 16312篇 |
2015年 | 19501篇 |
2014年 | 26747篇 |
2013年 | 37722篇 |
2012年 | 51876篇 |
2011年 | 54462篇 |
2010年 | 34119篇 |
2009年 | 31936篇 |
2008年 | 50231篇 |
2007年 | 53345篇 |
2006年 | 52984篇 |
2005年 | 50150篇 |
2004年 | 47760篇 |
2003年 | 46136篇 |
2002年 | 44586篇 |
2001年 | 89504篇 |
2000年 | 92278篇 |
1999年 | 77604篇 |
1998年 | 20047篇 |
1997年 | 17798篇 |
1996年 | 17696篇 |
1995年 | 16628篇 |
1994年 | 15632篇 |
1993年 | 14362篇 |
1992年 | 58710篇 |
1991年 | 56533篇 |
1990年 | 54739篇 |
1989年 | 52649篇 |
1988年 | 48144篇 |
1987年 | 47022篇 |
1986年 | 43617篇 |
1985年 | 41560篇 |
1984年 | 30312篇 |
1983年 | 25306篇 |
1982年 | 14121篇 |
1981年 | 12654篇 |
1979年 | 26308篇 |
1978年 | 17858篇 |
1977年 | 15240篇 |
1976年 | 13697篇 |
1975年 | 15034篇 |
1974年 | 17476篇 |
1973年 | 16750篇 |
1972年 | 15556篇 |
1971年 | 14275篇 |
1970年 | 13392篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
心房颤动的导管消融治疗 总被引:9,自引:0,他引:9
心房颤动(简称“房颤”)是心血管疾病中无论在控制症状方面还是改善预后方面均不理想的病种。房颤的导管消融作为一种新的治疗手段,从10年前诞生之日起就引发了房颤治疗的革命,近2年来,越来越多的国内外医学中心已将其作为房颤的常规治疗。本文就现阶段如何选择房颤导管消融治疗的适应证作简要评价。1目前的方法简介由于迄今的资料充分证实房颤的起源90%以上位于肺静脉及其与左房后壁的过渡区域(肺静脉前庭),导管根治房颤的方法也就集中在将该区域与左房之间的电学传导阻断。目前的主流方法是在三维标测系统CARTO或NavX指导下行肺静脉隔… 相似文献
62.
p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens 总被引:3,自引:0,他引:3
Primary chemotherapy administered to breast cancer patientsis the best model to identify baseline features able to predictwhich patients may be most likely to benefit or not from a cytotoxicregimen. In the March issue of Annals of Oncology two papersevaluated the predictive role of immunohistochemical p53 expressionon 相似文献
63.
64.
65.
S F Wong A Lee-Tannock D Amaraddio F Y Chan H D McIntyre 《Ultrasound in obstetrics & gynecology》2006,28(7):934-938
OBJECTIVE: To assess the effect of glucose control on the rate of growth of fetuses in women with pregestational diabetes mellitus (Types 1 and 2). METHODS: All pregestational diabetic women booked at Mater Mothers' Hospital, Brisbane, Australia, between 1 January 1994 and 31 December 2002, were included. Pregnancies with congenital fetal anomalies, multiple pregnancies, and pregnancies terminated prior to 20 weeks' gestation were excluded. Dating scans were performed before 14 weeks' gestation and serial scans were performed at 18, 24, 28, 32 and 36 weeks. Fetal parameters, including biparietal diameter, femur length and abdominal circumference, were recorded. The daily growth rates for biparietal diameter, femur length, and fetal abdominal area were calculated and compared with those in a low-risk (non-diabetic) population. The growth rates in fetuses of women with satisfactory diabetic control (HbA1c < 6.5%) and unsatisfactory control (HbA1c > or = 6.5%) in the three trimesters were compared. RESULTS: A total of 174 diabetic pregnancies were included and a total of 997 ultrasound scans were performed. The growth rates for fetuses of mothers with diabetes mellitus were significantly higher than for those in the low-risk population. The z-scores for biparietal diameter, femur length, and fetal abdominal area were 0.18, 0.59 and 1.44, respectively. Fetuses of diabetic mothers with high HbA1c in the first trimester had significantly greater fetal abdominal area growth rate than those with normal HbA1c (fetal abdominal area z-score of 1.7 vs. 0.75, P = 0.009). Although the fetal abdominal area z-scores in fetuses of diabetic mothers with high HbA1c in the second or third trimesters were also higher than those with normal HbA1c levels, the differences did not reach statistical significance. Maternal obesity did not influence the fetal growth rate. CONCLUSION: The rate of growth of fetuses of diabetic mothers differs from that of the normal population. Growth acceleration persists until the late third trimester. Moreover, periconceptional glucose control appears to have a significant effect on accelerated growth of the fetal abdominal area. 相似文献
66.
贺晓新 《结核与肺部疾病杂志》2006,1(3):153-156
科学研究的目标是创造和传播知识。这得通过对系统收集以及报告信息的批判性分析来完成。批判性分析始于一个简单的步骤,即在运用复杂统计学分析方法进行比较之前对所收集的数据进行深入检查。根据所收集的数据类型按照标准化方式进行统计学分析。在为解决研究问题而需采用合理、标准化步骤进行比较时,新知识就产生了,同时要避免错误的结论。在对数据进行仔细检查和分析之后,为了保证结论的正确性,再对数据进行一次批判性评论是非常重要的补充步骤。在科学文献中发表研究成果过程中涉及的同行评价对于传播新知识并保证其质量方面是一个非常重要的步骤。如果没有将研究成果发表供同行参考,这项研究就不算完整。 相似文献
67.
A. Nakao H. Toyokawa A. Tsung M. A. Nalesnik D. B. Stolz J. Kohmoto A. Ikeda K. Tomiyama T. Harada T. Takahashi R. Yang M. P. Fink K. Morita A. M. K. Choi N. Murase 《American journal of transplantation》2006,6(10):2243-2255
Carbon monoxide (CO), a byproduct of heme catalysis, was shown to have potent cytoprotective and anti-inflammatory effects. In vivo recipient CO inhalation at low concentrations prevented ischemia/reperfusion (I/R) injury associated with small intestinal transplantation (SITx). This study examined whether ex vivo delivery of CO in University of Wisconsin (UW) solution could ameliorate intestinal I/R injury. Orthotopic syngenic SITx was performed in Lewis rats after 6 h cold preservation in control UW or UW that was bubbled with CO gas (0.1-5%) (CO-UW). Recipient survival with intestinal grafts preserved in 5%, but not 0.1%, CO-UW improved to 86.7% (13/15) from 53% (9/17) with control UW. At 3 h after SITx, grafts stored in 5% CO-UW showed improved intestinal barrier function, less mucosal denudation and reduced inflammatory mediator upregulation compared to those in control UW. Preservation in CO-UW associated with reduced vascular resistance (end preservation), increased graft cyclic guanosine monophosphate levels (1 h), and improved graft blood flow (1 h). Protective effects of CO-UW were reversed by ODQ, an inhibitor of soluble guanylyl cyclase. In vitro culture experiment also showed better preservation of vascular endothelial cells with CO-UW. The study suggests that ex vivo CO delivery into UW solution would be a simple and innovative therapeutic strategy to prevent transplant-induced I/R injury. 相似文献
68.
69.
The antiepileptic efficacy and tolerability of oxcarbazepine, used both as monotherapy and adjunctive therapy, were observed for 1 year in 202 adult patients, aged 17-83 years, with newly diagnosed or refractory partial epilepsy in clinical practice in Italy. At first observation, the seizure free rate was 72.2% in newly diagnosed patients given monotherapy, 40% in patients in whom oxcarbazepine replaced another monotherapy and 10.3% in patients given oxcarbazepine as adjunctive therapy. At least 50% reduction in seizure frequency was achieved in 90.7, 72 and 57%, respectively. Efficacy increased with the duration of treatment (p < 0.0001). In the 160 completers the seizure free rate was 61.3% with monotherapy and 28% with adjunctive therapy. 16.3% of patients reported adverse effects, mainly sedation and sleepiness; 5% discontinued oxcarbazepine because of adverse events. OXC is an effective and well-tolerated antiepileptic agent for the long-term treatment of partial epilepsy in adults. 相似文献
70.